Literature DB >> 9618284

Leptin receptor signal transduction: OBRa and OBRb of fa type.

T Yamashita1, T Murakami, S Otani, M Kuwajima, K Shima.   

Abstract

We report herein the characterization of activities of signal transduction for three types of leptin receptors (OBRs) from rats, the OBRa, OBRb, and OBRb with fa mutation (OBRb-fa), by measurement of the levels of tyrosine phosphorylation of STAT3 (signal transducers and activators of transcription 3) and MAPK (mitogen-activated protein kinase), which are induced by leptin stimulation of CHO cells stably expressing the OBR (CHO-OBRb, CHO-OBRa, or CHO-OBRb-fa cells). As the result of leptin stimulation, enhanced levels of tyrosine phosphorylation of STAT3 and MAPK were detected in CHO-OBRb cells. In CHO-OBRb-fa cells, enhancement levels for both were lower than those in CHO-OBRb cells. In CHO-OBRa cells, only the phosphorylation of MAPK was detected. These data suggest that these reduced signaling activities cause obesity in fa/fa rats and that OBRa, which has been generally thought to be inactive at signaling, actually transmits signals through the MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618284     DOI: 10.1006/bbrc.1998.8689

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

2.  ObRb downregulation increases breast cancer cell sensitivity to tamoxifen.

Authors:  Yingying Qian; Dongmin Shi; Jinrong Qiu; Fang Zhu; Jing Qian; Shaohua He; Yongqian Shu; Yongmei Yin; Xiaofeng Chen
Journal:  Tumour Biol       Date:  2015-04-07

Review 3.  Olfaction under metabolic influences.

Authors:  Brigitte Palouzier-Paulignan; Marie-Christine Lacroix; Pascaline Aimé; Christine Baly; Monique Caillol; Patrice Congar; A Karyn Julliard; Kristal Tucker; Debra Ann Fadool
Journal:  Chem Senses       Date:  2012-07-25       Impact factor: 3.160

4.  Anterior pituitary corticotropes of adrenalectomized, leptin-administered rats.

Authors:  L K Malendowicz; A Ziólkowska; M Trejter
Journal:  Pituitary       Date:  2001 Jan-Apr       Impact factor: 4.107

5.  Metabolic regulation of APOBEC-1 complementation factor trafficking in mouse models of obesity and its positive correlation with the expression of ApoB protein in hepatocytes.

Authors:  Chad A Galloway; John Ashton; Janet D Sparks; Robert A Mooney; Harold C Smith
Journal:  Biochim Biophys Acta       Date:  2010-06-09

6.  Leptin inhibits stress-induced apoptosis of T lymphocytes.

Authors:  Y Fujita; M Murakami; Y Ogawa; H Masuzaki; M Tanaka; S Ozaki; K Nakao; T Mimori
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells.

Authors:  Cinzia Giordano; Donatella Vizza; Salvatore Panza; Ines Barone; Daniela Bonofiglio; Marilena Lanzino; Diego Sisci; Francesca De Amicis; Suzanne A W Fuqua; Stefania Catalano; Sebastiano Andò
Journal:  Mol Oncol       Date:  2012-11-23       Impact factor: 6.603

8.  Leptin interferes with 3',5'-cyclic adenosine monophosphate (cAMP) signaling to inhibit steroidogenesis in human granulosa cells.

Authors:  Qing Lin; Song Ling Poon; Junling Chen; Linan Cheng; Basil HoYuen; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-10-22       Impact factor: 5.211

9.  The effect of leptin on luteal angiogenic factors during the luteal phase of the estrous cycle in goats.

Authors:  Jessica R Wiles; Robin A Katchko; Elizabeth A Benavides; Chad W O'Gorman; Jean M Escudero; Duane H Keisler; Randy L Stanko; Michelle R Garcia
Journal:  Anim Reprod Sci       Date:  2014-06-02       Impact factor: 2.145

10.  Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase.

Authors:  P Fernández-Riejos; R Goberna; V Sánchez-Margalet
Journal:  Clin Exp Immunol       Date:  2008-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.